Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver cancer.

A Aguayo1, Y Z Patt

  • 1Department of Gastrointestinal Medical Oncology, Division of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Clinics in Liver Disease
|June 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the influence of main groundwater ions on arsenic removal by limestones through column experiments.

The Science of the total environment·2020
Same author

Prevalence of diabetes mellitus and impaired glucose metabolism in the adult population of the Basque Country, Spain.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Clinical and genetic characterization of congenital hyperinsulinism in Spain.

European journal of endocrinology·2016
Same author

Symbol Digit Modalities Test: Normative data for the Latin American Spanish speaking adult population.

NeuroRehabilitation·2015
Same author

Brief Test of Attention: Normative data for the Latin American Spanish speaking adult population.

NeuroRehabilitation·2015
Same author

Trail Making Test: Normative data for the Latin American Spanish speaking adult population.

NeuroRehabilitation·2015
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Hepatocellular carcinoma (HCC) has a poor prognosis, but prevention strategies show promise. Neonatal vaccination significantly reduced childhood HCC rates in Taiwan, and treatments for viral hepatitis may lower long-term HCC development.

Area of Science:

  • Hepatology
  • Oncology
  • Public Health

Background:

  • Hepatocellular carcinoma (HCC) presents a dismal prognosis, with 5-year survival rates below 25% even for surgically resectable cases and median survival under 1 year for advanced disease.
  • Despite poor prognosis, HCC is a preventable malignancy, offering hope for improved patient outcomes.

Purpose of the Study:

  • To highlight the preventable nature of Hepatocellular carcinoma (HCC).
  • To review successful public health interventions and ongoing research for HCC prevention.

Main Methods:

  • Analysis of HCC incidence rates in Taiwanese children before and after the implementation of a neonatal vaccination program.
  • Review of existing literature on antiviral therapies (e.g., Interferon) for viral hepatitis in relation to HCC development.

Related Experiment Videos

  • Examination of investigational agents (e.g., polyprenoic acid, acyclic retinoid) for preventing secondary primary tumors post-HCC resection.

    • Main Results:

    • A significant decrease in childhood HCC rates (from 5.2 to 1.3 per million) was observed in Taiwan following the 1984 neonatal vaccination program.
    • Interferon treatment for viral hepatitis shows potential in reducing long-term HCC incidence.
    • Research is ongoing into agents like polyprenoic acid and acyclic retinoid for preventing recurrence after HCC resection.

    Conclusions:

    • Hepatocellular carcinoma (HCC) is a preventable disease, with vaccination programs demonstrating substantial public health impact.
    • Antiviral therapies and novel chemopreventive agents represent key strategies in the ongoing fight against HCC.